ICICIGI and GICRE, both in Specialty Insurance. Monthly data through 2026-10-09. Change the comparison →
Share price change since Jan '19, the first month all 2 have a price: ICICIGI +92%, GICRE +37%.
Rebased at 2019-01. Monthly closes from each company's history.
Months with a missing value are left as gaps.
The share price return over 3 years, split into net profit growth, share count change and the change in P/E.
ICICIGI: share price rose 23% over 3 years: +38 pts from net profit growth, −13 pts from the P/E change, −2 pts from share count change.
GICRE: share price rose 46% over 3 years: +37 pts from net profit growth, +9 pts from the P/E change.
Segments are percentage points of the price return: price = P/E × net profit ÷ share count. These are the same numbers each company's own page shows.
Each cell is the company's percentile rank among its own sector peers that month. Darker is higher-ranked. Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value.
| Metric | ICICIGI | GICRE |
|---|---|---|
| Share Price | ₹1690.20 | ₹312.60 |
| Market Cap | ₹84233 cr | ₹54835 cr |
| P/E | 34.7x | 6.4x |
| P/B | 5.1x | 0.8x |
| P/S | 3.0x | 1.0x |
| ROCE | 22.0% | 18.0% |
| ROE | 14.6% | 13.2% |
| Operating margin | 7.0% | 15.0% |
| Revenue (TTM), indexed to 100 | ₹27687 cr | ₹52413 cr |
| Net Profit (TTM) | ₹2429 cr | ₹8562 cr |
| Debt / Equity | 0.0x | 0.0x |
| Cash Conversion Cycle | 0d | 0d |
| Promoter holding | 51.2% | 77.4% |
| FII Holding | 21.4% | 2.4% |
| DII Holding | 20.6% | 17.7% |
| 12M momentum | -15.2% | -13.2% |
| Drawdown from Peak | -22.3% | -24.9% |
| Cash conversion (3Y) | 0.9x | -0.1x |
| Share Count Change (1Y) | 0.4% | 0.0% |
| Volatility (1Y) | 26.2% | 24.2% |
Latest month in the data: 2026-10. Highlight marks the higher value, or the lower value for P/E, P/B, P/S, debt, working-capital days, share count change and volatility. It marks a number, not a better investment.
Comparison is descriptive and historical. Highlights mark the higher or lower value on a metric, not a better investment. Not investment advice; ApnaFunda is not a SEBI-registered research analyst.